Tim M Reynolds
Affiliation: Birmingham Heartlands Hospital
- Down's syndrome screening: a controversial test, with more controversy to come!T M Reynolds
Queen s Hospital and Division of Clinical Sciences, Wolverhampton University, Wolverhampton WV1 1SB, UK
J Clin Pathol 53:893-8. 2000..Furthermore, if a national policy is decided upon, worldwide patent searches should be carried out to determine whether there are any possible unforeseen legal consequences of any recommendation...
- Accuracy of cardiovascular risk estimation for primary prevention in patients without diabetesTimothy M Reynolds
Queen s Hospital, Burton on Trent, Staffordshire and Division of Clinical Sciences, Wolverhampton University, UK
J Cardiovasc Risk 9:183-90. 2002..We investigated the effects of biological variation in risk factors on risk estimate accuracy and whether current primary prevention screening (risk assessment) models correctly categorize patients...
- Hemoglobin Wayne in a British family: identification by electrospray ionization/mass spectrometryTim M Reynolds
Clinical Chemistry Department, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, United Kingdom
Clin Chem 48:2261-3. 2002
- Does activity in research correlate with visibility?T M Reynolds
Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
J Clin Pathol 57:426-7. 2004..It could be considered that published research that is not cited in other work is not useful unless it has achieved visibility, as demonstrated by citation in another research publication...
- Randomized clinical trial comparing 2 support surfaces: results of the Prevention of Pressure Ulcers StudyLinda J Russell
Queen s Hospital, Burton on Trent, UK
Adv Skin Wound Care 16:317-27. 2003..To determine whether a viscoelastic polymer (energy absorbing) foam mattress was superior to a standard hospital mattress for pressure ulcer prevention and to analyze the cost-effectiveness in comparison with standard hospital mattresses...
- Implications of method specific creatinine adjustments on General Medical Services chronic kidney disease classificationTimothy M Reynolds
Department of Chemical Pathology, Queen s Hospital, Burton on Trent, UK
J Clin Pathol 60:1048-50. 2007..To evaluate the impact of different equations for calculation of estimated glomerular filtration rate (eGFR) on general practitioner (GP) workload...
- Can we manage demand for allergy testing by restricting requests to a small number of prime target allergens?Timothy M Reynolds
Department of Chemical Pathology, Queen s Hospital, Burton on Trent, Staffordshire DE13 0RB, UK
Ann Clin Biochem 44:467-70. 2007..Different hospitals have different policies on allergen testing. We report a comparison of the effect of requesting policy on diagnostic yield...
- Concordance evaluation of coronary risk scores: implications for cardiovascular risk screeningTimothy M Reynolds
Consultant Chemical Pathologist, Queen s Hospital, Burton on Trent and Division of Clinical Sciences, Wolverhampton University, UK
Curr Med Res Opin 20:811-8. 2004..The predictive capacities of 3 different risk identification systems based on computer calculation (the Framingham algorithm), or on tabular methods (the Sheffield tables and the General Rule to Enable Atheroma Treatment) were evaluated...
- Targeted versus global approaches to the management of hypercholesterolaemiaTimothy M Reynolds
Clinical Chemistry Dept, Queen s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK
J R Soc Promot Health 128:248-54. 2008..However, there is debate about the most effective approach to primary prevention. This study simulated the effects of directed versus global approaches for intervention on coronary heart disease (CHD) event rates...
- More on PROSPERAnthony S Wierzbicki
Lancet 361:1135-6; author reply 1136. 2003
- Accuracy of cardiovascular risk estimationTimothy M Reynolds
Clin Chem 49:706-7. 2003
- Cost utility of prenatal diagnosisAnthony S Wierzbicki
Lancet 363:1165. 2004
- Non-ceruloplasmin-bound copper in routine clinical practice in different laboratoriesPatrick J Twomey
Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich IP4 5PD, UK
J Trace Elem Med Biol 22:50-3. 2008..Non-ceruloplasmin-bound copper is a calculated parameter devised for the investigation of patients who potentially have WD...
- Usefulness of Orlistat in the treatment of severe hypertriglyceridemiaAnthony S Wierzbicki
Department of Chemical Pathology, St Thomas Hospital, London, United Kingdom
Am J Cardiol 89:229-31. 2002
- Copper:caeruloplasmin ratioPatrick J Twomey
Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich, UK
J Clin Pathol 60:441-2. 2007..Caeruloplasmin assays also have uncertainty from precision, bias and specificity and, accordingly, method-related differences may have a large effect on the copper:caeruloplasmin ratio in a manner similar to the NCC...
- Prevalence of kidney disease and estimated GFR in routine practiceTimothy M Reynolds
Ann Clin Biochem 43:84-5; author reply 86-7. 2006
- Cardiovascular risk assessmentAnthony S Wierzbicki
Lancet 365:1305-6. 2005
- Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetesPatrick J Twomey
Diabetes Care 27:2569-70. 2004
- Screening for cardiovascular diseaseAnthony S Wierzbicki
Eur Heart J 25:996; author reply 996-7. 2004
- Issues to consider when attempting to achieve the American Diabetes Association clinical quality requirement for haemoglobin A1cPatrick J Twomey
Specialist Registrar in Clinical Biochemistry, Edinburgh Royal Infirmary, Edinburgh, UK
Curr Med Res Opin 19:719-23. 2003..Delta check' criteria ought to be applied and results reported to highlight acute deviations in A1C. Such procedures will aid the attainment of the clinical quality requirements and give appropriate results for audit purposes...
- Use of coronary calcification scores to predict coronary heart diseaseAnthony S Wierzbicki
JAMA 291:1831; author reply 1832-3. 2004